systemic%20lupus%20erythematosus%20(pediatric)
SYSTEMIC LUPUS ERYTHEMATOSUS (PEDIATRIC)
Systemic lupus erythematosus is a chronic, multisystem, inflammatory, autoimmune disorder characterized by formation of autoantibodies directed against self-antigens and immune-complex formation.
It can be suspected when ≥2 organ systems are involved.
It is predominantly diagnosed in females of childbearing age, rarely diagnosed before 8 years old.
Clinical presentation varies in different patients and the disease activity varies over time in a single patient. Majority of patients have arthralgia of the hand.

Diagnosis

Diagnosis of systemic lupus erythematosus (SLE) is based on clinical symptoms & lab findings

Diagnosis based on the Systemic Lupus International Collaborating Clinics (SLICC) classification criteria for systemic lupus erythematosus (SLE)

  • ≥4 criteria (at least 1 clinical & 1 immunologic criteria) or biopsy-proven lupus nephritis w/ positive antinuclear antibody (ANA) or anti-double stranded deoxyribonucleic acid (dsDNA)
  • Symptom/finding need not be present all at the same time

Clinical Criteria:

  • Acute cutaneous lupus, including:
    • Lupus malar rash (do not count if malar discoid)
    • Bullous lupus
    • Toxic epidermal necrolysis variant of systemic lupus erythematosus (SLE)
    • Maculopapular lupus rash
    • Photosensitive lupus rash (In the absence of dermatomyositis) or
    •  Subacute cutaneous lupus (nonindurated psoriaform &/or annular polycyclic lesions that resolve w/out scarring, although occasionally w/ post-inflammatory dyspigmentation or telangiectasias)
  • Chronic cutaneous lupus, including:
    • Classic discoid rash: localized (above the neck) or generalized (above & below the neck)
    • Hypertrophic (verrucous) lupus
    • Lupus panniculitis (profundus)
    • Mucosal lupus
    • Lupus erythematosus tumidus
    • Chilblains lupus
    • Discoid lupus/lichen planus overlap
  • Oral Ulcers or Nasal Ulcers
    • Oral: palate, buccal, tongue
    • In the absence of other causes, such as vasculitis, Behcet’s disease, infection (herpesvirus), inflammatory bowel disease, reactive arthritis, & acidic foods
  • Nonscarring alopecia
    • Diffuse thinning or hair fragility w/ visible broken hairs
    • In the absence of other causes such as alopecia areata, drugs, iron deficiency, & androgenic alopecia
  • Synovitis involving ≥2 joints
    • Characterized by swelling or effusion
    • Or tenderness in ≥2 joints & at least 30 minutes of morning stiffness
  • Serositis
    • Typical pleurisy for >1 day or pleural effusions or pleural rub
    • Typical pericardial pain (pain w/ recumbency improved by sitting forward) for >1 day or pericardial effusion or pericardial rub or pericarditis by electrocardiography
    • In the absence of other causes, such as infection, uremia, & Dressler’s pericarditis
  • Renal
    • Urine protein–to-creatinine ratio (or 24-hour urine protein) representing 500 mg protein/24 hours or red blood cell casts
  • Neurologic
    • Seizures
    • Psychosis
    • Mononeuritis multiplex (in the absence of other known causes such as primary vasculitis)
    • Myelitis
    • Peripheral or cranial neuropathy (in the absence of other known causes such as primary vasculitis, infection, & diabetes mellitus)
    • Acute confusional state (in the absence of other causes, including toxic/metabolic, uremia, drugs) 
  • Hemolytic anemia
  • Leukopenia (<4000/mm3) at least once, in the absence of other known causes such as Felty’s syndrome, drugs, & portal hypertension or Lymphopenia (<1000/mm3) at least once, in the absence of other known causes such as corticosteroids, drugs, & infection
  • Thrombocytopenia (<100,000/mm3)
    • At least once in the absence of other known causes such as drugs, portal hypertension, & thrombotic thrombocytopenic purpura

Immunologic Criteria:

  • Antinuclear antibodies (ANA) level above laboratory reference range
  • Anti-double stranded deoxyribonucleic acid (dsDNA) antibody level above laboratory reference range [or >2-fold the reference range if tested by enzyme-linked immunosorbent assay (ELISA)]
  • Anti-Smith (Anti-Sm): presence of antibody to Smith (Sm) nuclear antigen
  • Antiphospholipid antibody positivity, as determined by:
    • Positive test for lupus anticoagulant
    • False-positive test result for rapid plasma reagin
    • Medium- or high-titer anticardiolipin antibody level  [Immunoglobulin A (IgA), immunoglobulin G (IgG) or immunoglobulin M (IgM)]
    • Positive test result for anti-B2-glycoprotein I [Immunoglobulin A (IgA), immunoglobulin G (IgG) or immunoglobulin M (IgM)]
  • Low complement (C3, C4, or CH50)
  • Direct Coombs’ test (in the absence of hemolytic anemia)

Expert Referral

  • Establish good working relationship amongst the primary care physician, pediatrician, rheumatologist, nurse, pharmacist, other healthcare providers, the patient & his/her family
    • Team approach will allow for earlier identification of disease flares & medication toxicity
  • Patient will initially present to a primary care physician/pediatrician who is responsible for:
    • Recognizing the signs & symptoms of systemic lupus erythematosus (SLE) in their patients
    • Making an initial diagnosis
    • Managing & monitoring patients w/ mild & stable systemic lupus erythematosus (SLE)
    • Referring patient to a rheumatologist & participating in further systemic lupus erythematosus (SLE) diagnosis, management & monitoring
  • A rheumatologist is an integral part of the medical team managing an systemic lupus erythematosus (SLE) patient
  • Referral to a rheumatologist is indicated for:
    • Confirmation of diagnosis
    • Management plan for patient
    • Periodic evaluation of disease activity & severity
    • Management of uncontrolled disease
    • Management of organ involvement or life-threatening disease
    • Prevention &/or management of treatment toxicities
    • Special situations eg pregnancy, antiphospholipid syndrome, life-threatening disease, concomitant infection & surgery 
  • Systemic lupus erythematosus (SLE) patients should be referred to psychologist, psychiatrist, physical &/or occupational therapist, ophthalmologist, dermatologist, nephrologist, cardiologist, orthopedic surgeon & other specialists when necessary
    • If there are signs of renal involvement, patient should be referred to a nephrologist for management
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS JPOG - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
Jairia Dela Cruz, 13 Oct 2016
Children born to obese mothers are at increased risk of developing autism spectrum disorder (ASD) compared with children born to normal-weight mothers, according to data from a review and meta-analysis.
Yap Te-Lu, Anette Sundfor Jacobsen, 01 Oct 2013

Antenatal hydronephrosis (ANH) is a general term used to describe the dilatation of the fetal renal pelvis and/or its calyces. In pelviectasis, there is only dilatation of the renal pelvis; while in caliectasis, there is dilatation of the calyces. ANH is the most commonly diagnosed congenital urinary tract anomaly, which is detected by prenatal screening in 1–5% of all pregnancies

Yap Te-Lu, Anette Sundfor Jacobsen, 01 Dec 2012

Antenatal hydronephrosis (ANH) is a general term used to describe the dilatation of the fetal renal pelvis and/or its calyces. In pelviectasis, there is only dilatation of the renal pelvis; while in caliectasis, there is dilatation of the calyces. ANH is the most commonly diagnosed congenital urinary tract anomaly, which is detected by prenatal screening in 1–5% of all pregnancies.

Yap Te-Lu, Anette Sundfor Jacobsen, 01 Apr 2011

Antenatal hydronephrosis (ANH) is a general term used to describe the dilatation of the fetal renal pelvis and/or its calyces. In pelviectasis, there is only dilatation of the renal pelvis; while in caliectasis, there is dilatation of the calyces. ANH is the most commonly diagnosed congenital urinary tract anomaly, which is detected by prenatal screening in 1–5% of all pregnancies.